Search

New results from a clinical trial led by Memorial Sloan Kettering Cancer Center (MSK), gastrointestinal oncologists Andrea Cercek, MD, and Luis Diaz Jr., MD, demonstrates how immunotherapy alone can allow people with MMRd cancers to avoid surgery and preserve their quality of life.

… Sunday, April 27, 2025 CHICAGO —   New results from a clinical trial led by Memorial Sloan Kettering Cancer Center (MSK), gastrointestinal oncologists  Andrea Cercek, MD , and  Luis Diaz Jr., MD, demonstrate how immunotherapy alone can allow people with  MMRd cancers to avoid surgery and preserve their

Women want to understand and decrease their risk of breast cancer, and Nicole Saphier, MD, Director of Breast Imaging at MSK Monmouth, wants to ensure that women make the right decisions when it comes to their breast health this October, in honor of Breast Cancer Awareness Month, and every day.

… Tuesday, October 23, 2018 Women want to understand and decrease their risk of  breast cancer ,  and Nicole Saphier, MD , Director of Breast Imaging at  MSK Monmouth , wants to ensure that women make the right decisions when it comes to their breast health this October, in honor of Breast Cancer Awareness

Total neoadjuvant therapy is a viable treatment strategy for patients with locally advanced rectal cancer and is associated with the potential to sidestep surgical treatment.

… Monday, September 10, 2018 Total neoadjuvant therapy is a viable treatment strategy for patients with locally advanced rectal cancer and is associated with improved delivery of planned therapy, increased downstaging, earlier introduction of optimal systemic chemotherapy to address micrometastases, and

Signet ring cell cancer (SRCC) was detected in the vast majority of patients with CDH1 mutations following total gastrectomy.

… Monday, July 11, 2022 Signet ring cell cancer (SRCC) was detected in the vast majority of patients with CDH1 mutations following total gastrectomy, according to a study Memorial Sloan Kettering Cancer Center (MSK) physicians published in JAMA Surgery .  (1) With the increasing availability of genomic

Learn about how MSK staff members recently participated in the 2021 Forbes China Healthcare Summit and spoke about how the war on cancer must be fought internationally with teams collaborating across political boundaries.

… Thursday, September 23, 2021 No one doctor, institution, or country can cure cancer on their own. The war on cancer must be fought internationally with teams collaborating across political boundaries. That was the key message of the 2021 Forbes China Healthcare Summit, which brought together leaders

Intensity-modulated radiation therapy (IMRT) confers a lower risk of femoral fracture in patients with primary soft tissue sarcoma of the thigh or groin, despite a higher dose of radiation to the target volume compared to conventional radiation.

… Monday, May 13, 2019 Intensity-modulated radiation therapy (IMRT) confers a lower risk of femoral fracture in patients with primary soft tissue sarcoma of the thigh or groin, despite a higher dose of radiation to the target volume compared to conventional radiation, according to the results of our study

Learn more about Ken Manotti, who leads philanthropic fundraising efforts at Memorial Sloan Kettering Cancer Center, where he is a Senior Vice President and Chief Development Officer.

… Wednesday, January 1, 2020 Why did you choose philanthropy as a career? I had no plans to be in this profession. But many years ago, a mentor asked me to help with fundraising at the University of Pennsylvania. She was very patient and taught me how to raise money for good causes. Is it hard asking people

Cody Bass was diagnosed with metastatic kidney cancer when he was 17. Two years later, he has no evidence of disease, thanks to a clinical trial at MSK.

… Thursday, September 5, 2024 For most teenagers, the summer before their senior year of high school is a time to hang out with friends, work a part-time job, and start thinking about college applications. But Cody Bass spent that summer recovering from a major operation at Memorial Sloan Kettering Cancer

MSK researchers have discovered a new mechanism of resistance to KRAS inhibitors that suggests an opportunity to make the treatment more effective.

… Thursday, July 11, 2024 Mutations in the KRAS gene are the primary driver of  pancreatic cancer . A new class of drugs known as KRAS inhibitors is showing initial promise in clinical trials, but many tumors quickly develop resistance to the treatment. Now, researchers at Memorial Sloan Kettering Cancer

… Monday, January 5, 2026 Memorial Sloan Kettering Cancer Center (MSK) today announced the following awards and appointments: Jason Lewis Elected as a Fellow of the National Academy of Inventors (NAI)   Jason Lewis Jason Lewis, PhD , Radiochemist, Emily Tow Chair in Oncology; Deputy Director, Sloan Kettering